Plain-English translation of NCT03192462 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Read our Pancreatic cancer research guide →Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
United States
Phase
Safety & dosing / Early efficacy
Sponsor
Baylor College of Medicine
Collaborators
Center for Cell and Gene Therapy, Baylor College of Medicine, The Methodist Hospital Research Institute
Enrollment target
~37 participants
Started
January 2018
Primary completion
June 2020
Age range
18 Years and older
Last updated on clinicaltrials.gov in October 2025.